Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Stoppa

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Molecular and Cellular Endocrinology|May 3, 2006
Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinomaM Di Benedetto, P Pineau, S Nouet, et al.
International Journal of Cancer|July 10, 1999
Germline brca2 sequence variants in patients with ocular melanomaO M Sinilnikova, K M Egan, J L Quinn, et al.
Journal of Medical Genetics|November 1, 2005
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndromeG Bougeard, S Baert-Desurmont, I Tournier, et al.
Cancer Research|July 15, 1996
Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancersH Sobol, D Stoppa-Lyonnet, B Bressac-de-Paillerets, et al.
International Journal of Cancer|June 19, 2001
Cancer risk in heterozygotes for ataxia-telangiectasiaB Geoffroy-Perez, N Janin, K Ossian, et al.
Pathologie-Biologie|February 2, 2010
[Genetic testing in the context of the revision of the French law on bioethics]D Bonneau, S Marlin, D Sanlaville, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 1999
Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative GroupH F Vasen, N E Haites, D G Evans, et al.
Human Mutation|January 15, 2004
Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSFC Houdayer, M Gauthier-Villars, A Laugé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Familial invasive breast cancers: worse outcome related to BRCA1 mutationsD Stoppa-Lyonnet, Y Ansquer, H Dreyfus, et al.
Disease Markers|December 14, 1999
Utilisation of prophylactic mastectomy in 10 European centresD G Evans, E Anderson, F Lalloo, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Molecular and Cellular Endocrinology|May 3, 2006
Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinomaM Di Benedetto, P Pineau, S Nouet, et al.
International Journal of Cancer|July 10, 1999
Germline brca2 sequence variants in patients with ocular melanomaO M Sinilnikova, K M Egan, J L Quinn, et al.
Journal of Medical Genetics|November 1, 2005
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndromeG Bougeard, S Baert-Desurmont, I Tournier, et al.
Cancer Research|July 15, 1996
Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancersH Sobol, D Stoppa-Lyonnet, B Bressac-de-Paillerets, et al.
International Journal of Cancer|June 19, 2001
Cancer risk in heterozygotes for ataxia-telangiectasiaB Geoffroy-Perez, N Janin, K Ossian, et al.
Pathologie-Biologie|February 2, 2010
[Genetic testing in the context of the revision of the French law on bioethics]D Bonneau, S Marlin, D Sanlaville, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 1999
Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative GroupH F Vasen, N E Haites, D G Evans, et al.
Human Mutation|January 15, 2004
Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSFC Houdayer, M Gauthier-Villars, A Laugé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Familial invasive breast cancers: worse outcome related to BRCA1 mutationsD Stoppa-Lyonnet, Y Ansquer, H Dreyfus, et al.
Disease Markers|December 14, 1999
Utilisation of prophylactic mastectomy in 10 European centresD G Evans, E Anderson, F Lalloo, et al.
Pageof 10